Novartis India's Vice Chairman and Managing Director Ranjit Shahani speaks during a news conference in Mumbai on April 1, 2013. India's Supreme Court rejected a patent bid by Swiss drug giant Novartis in a landmark ruling that activists say will protect cheap generic drugs and save lives in developing nations.